(FY)Jul 31, 2024 | (Q4)Jul 31, 2024 | (Q3)Apr 30, 2024 | (Q2)Jan 31, 2024 | (Q1)Oct 31, 2023 | (FY)Jul 31, 2023 | (Q4)Jul 31, 2023 | (Q3)Apr 30, 2023 | (Q2)Jan 31, 2023 | (Q1)Oct 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 87.64%-14.52K | 98.74%-281 | 98.99%-191 | 86.11%-8.54K | 62.62%-5.51K | 46.72%-117.46K | -121.95%-22.35K | 43.78%-18.85K | 26.93%-61.52K | 92.80%-14.74K |
Net income from continuing operations | -131.92%-442.57K | -451.37%-336.23K | 21.46%-32.97K | 13.87%-38.33K | 19.19%-35.04K | 12.19%-190.83K | 6.94%-60.98K | -16.71%-41.98K | 42.60%-44.5K | -13.23%-43.36K |
Asset impairment expenditure | 27,218.16%271.72K | ---- | ---- | ---- | ---- | ---1K | ---- | ---- | ---- | ---- |
Other non cashItems | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | -150.00%-1 | -100,000.00%-1K |
Change In working capital | 110.19%156.32K | 66.25%64.22K | 41.73%32.78K | 275.04%29.79K | -0.33%29.53K | 626.26%74.37K | -77.00%38.63K | 67.04%23.13K | 42.74%-17.02K | 117.82%29.63K |
-Change in receivables | -99.88%65 | -150.67%-189 | 19.92%4.42K | 10.24%-2.83K | -102.57%-1.33K | 266.01%52.84K | 100.85%373 | 12.94%3.68K | -109.38%-3.15K | 308.88%51.93K |
-Change in prepaid assets | 757.89%625 | --0 | --0 | --0 | 133.33%625 | -100.62%-95 | -98.75%530 | -91.94%625 | 101.63%625 | -151.95%-1.88K |
-Change in payables and accrued expense | 619.55%155.63K | 70.73%64.41K | 50.71%28.36K | 325.11%32.62K | 248.03%30.24K | 793.02%21.63K | -77.74%37.73K | 564.75%18.82K | 41.89%-14.49K | 85.91%-20.43K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 87.64%-14.52K | 98.74%-282 | 98.99%-190 | 86.11%-8.54K | 62.62%-5.51K | 46.72%-117.46K | -121.95%-22.35K | 43.78%-18.85K | 26.93%-61.52K | 92.80%-14.74K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 99.63%-588 | 57.22%-977 | 0 | 0 | 100.42%389 | 83.19%-159.03K | 98.49%-2.28K | -9,701.54%-57.14K | 99.25%-6.22K | -363.80%-93.38K |
Net PPE purchase and sale | 99.46%-588 | ---977 | --0 | --0 | 100.42%389 | 88.48%-109.03K | ---- | ---- | 99.25%-6.22K | -363.80%-93.38K |
Net other investing changes | ---- | ---- | ---- | ---- | ---- | ---50K | --106.75K | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 99.63%-588 | 57.22%-977 | --0 | --0 | 100.42%389 | 83.19%-159.03K | 98.49%-2.28K | -9,701.54%-57.14K | 99.25%-6.22K | -363.80%-93.38K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 0 | 0 | 0 | -100.72%-1.21K | 0 | -582.86%-845 | ||||
Net other financing activities | ---- | ---- | ---- | ---- | ---- | 82.50%-1.21K | --0 | -585.63%-845 | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | --0 | --0 | --0 | ---- | ---- | -100.72%-1.21K | --0 | -582.86%-845 | ---- | ---- |
Net cash flow | ||||||||||
Beginning cash position | -90.31%29.81K | -70.69%15.96K | -87.70%16.15K | -87.62%24.69K | -90.31%29.81K | -76.45%307.51K | -84.73%54.44K | -66.38%131.29K | -82.46%199.39K | -76.45%307.51K |
Current changes in cash | 94.56%-15.11K | 94.89%-1.26K | 99.75%-191 | 87.46%-8.54K | 95.27%-5.12K | 72.19%-277.7K | 49.80%-24.63K | -126.37%-76.84K | 90.87%-68.11K | 36.08%-108.12K |
End cash Position | -50.69%14.7K | -50.69%14.7K | -70.69%15.96K | -87.70%16.15K | -87.62%24.69K | -90.31%29.81K | -90.31%29.81K | -84.73%54.44K | -66.38%131.29K | -82.46%199.39K |
Free cash from | 93.33%-15.11K | 99.34%-870 | -100.24%-190 | 87.39%-8.54K | 94.91%-5.51K | 80.58%-226.49K | -167.74%-131.38K | 336.67%80.75K | 92.29%-67.74K | 47.14%-108.12K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data